BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 8741079)

  • 1. Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.
    Kitze B; Usuku K; Izumo S; Nakamura M; Shiraki H; Ijichi S; Yashiki S; Fujiyoshi T; Sonoda S; Osame M
    J Neurol; 1996 May; 243(5):393-400. PubMed ID: 8741079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardisation of Western blotting to detect HTLV-1 antibodies synthesised in the central nervous system of HAM/TSP patients.
    Ribeiro LC; Gonçalves CC; Slater CM; Carvalho SM; Puccioni-Sohler M
    Mem Inst Oswaldo Cruz; 2013 Sep; 108(6):730-4. PubMed ID: 24037195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated antibodies to synthetic peptides of HTLV-1 envelope transmembrane glycoproteins in patients with HAM/TSP.
    Nakamura M; Kuroki M; Kira J; Itoyama Y; Shiraki H; Kuroda N; Washitani Y; Nakano S; Nagafuchi S; Anzai K
    J Neuroimmunol; 1991 Dec; 35(1-3):167-77. PubMed ID: 1955565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of intrathecal IgG synthesis for HTLV-1 core and envelope proteins in HAM/TSP.
    Kitze B; Puccioni-Sohler M; Schäffner J; Rieckmann P; Weber T; Felgenhauer K; Bodemer W
    Acta Neurol Scand; 1995 Sep; 92(3):213-7. PubMed ID: 7484074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of the antibody response to the HTLV-I gag and env proteins in HTLV-I asymptomatic carriers and HAM/TSP patients: an isotype and subclass analysis.
    Dekaban GA; King EE; Arp J; Palker TJ; Rice GP
    Scand J Immunol; 1994 Aug; 40(2):171-80. PubMed ID: 8047838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.
    Jacobson S; Reuben JS; Streilein RD; Palker TJ
    J Immunol; 1991 Feb; 146(4):1155-62. PubMed ID: 1704032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal humoral immune response in HAM/TSP in relation to HLA haplotype analysis.
    Kitze B; Usuku K; Yashiki S; Ijichi S; Fujiyoshi T; Nakamura M; Izumo S; Osame M; Sonoda S
    Acta Neurol Scand; 1996 Oct; 94(4):287-93. PubMed ID: 8937542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody titers to HTLV-I-p40tax protein and gag-env hybrid protein in HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with increased HTLV-I proviral DNA load.
    Kira J; Nakamura M; Sawada T; Koyanagi Y; Ohori N; Itoyama Y; Yamamoto N; Sakaki Y; Goto I
    J Neurol Sci; 1992 Jan; 107(1):98-104. PubMed ID: 1578240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Burbelo PD; Meoli E; Leahy HP; Graham J; Yao K; Oh U; Janik JE; Mahieux R; Kashanchi F; Iadarola MJ; Jacobson S
    Retrovirology; 2008 Oct; 5():96. PubMed ID: 18937847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease.
    Elovaara I; Koenig S; Brewah AY; Woods RM; Lehky T; Jacobson S
    J Exp Med; 1993 Jun; 177(6):1567-73. PubMed ID: 8496677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.
    Lal RB; Buckner C; Khabbaz RF; Kaplan JE; Reyes G; Hadlock K; Lipka J; Foung SK; Chan L; Coligan JE
    Clin Immunol Immunopathol; 1993 Apr; 67(1):40-9. PubMed ID: 7680300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals.
    Enose-Akahata Y; Abrams A; Massoud R; Bialuk I; Johnson KR; Green PL; Maloney EM; Jacobson S
    Retrovirology; 2013 Feb; 10():19. PubMed ID: 23405908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
    Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N
    J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals.
    Ida H; Kurata A; Eguchi K; Kawakami A; Migita K; Fukuda T; Nakamura T; Kusumoto Y; Berzofsky JA; Nagataki S
    J Clin Immunol; 1991 May; 11(3):143-51. PubMed ID: 1890164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Enose-Akahata Y; Jacobson S
    Retrovirology; 2019 Nov; 16(1):35. PubMed ID: 31783764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-dependent cell-mediated cytotoxicity (ADCC) in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Fujihara K; Itoyama Y; Yu F; Kubo C; Goto I
    J Neurol Sci; 1996 Oct; 142(1-2):65-9. PubMed ID: 8902722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of HTLV-1 gp46 glycoprotein from health carriers and HAM/TSP infected individuals.
    Mota-Miranda AC; Barreto FK; Amarante MF; Batista E; Monteiro-Cunha JP; Farre L; Galvão-Castro B; Alcantara LC
    Virol J; 2013 Mar; 10():75. PubMed ID: 23510700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infective dermatitis and human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in childhood and adolescence.
    Primo JR; Brites C; Oliveira Mde F; Moreno-Carvalho O; Machado M; Bittencourt AL
    Clin Infect Dis; 2005 Aug; 41(4):535-41. PubMed ID: 16028164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica.
    Enose-Akahata Y; Abrams A; Johnson KR; Maloney EM; Jacobson S
    Blood; 2012 Mar; 119(12):2829-36. PubMed ID: 22318200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.